Increased PD-L1 expression and PD-L1/CD86 ratio on dendritic cells were associated with impaired dendritic cells function in HCV infection

Journal of Medical Virology

Volumn 82, Issue 7, 2010, Pages 1152-1159

  Shen, Tao ^a   Chen, Xiangmei ^a   Chen, Yu ^b   Xu, Qiang ^a   Lu, Fengmin ^a   Liu, Shuang ^b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Hepatitis C virus; Myeloid dendritic cells; PD L1; Plasmacytoid dendritic cells

Indexed keywords

ALPHA INTERFERON; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CD274 PROTEIN, HUMAN; CD86 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; PROGRAMMED DEATH 1 LIGAND 1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; HEPATITIS C; HUMAN; HUMAN CELL; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN SECRETION; FEMALE; HEPACIVIRUS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; PHYSIOLOGY; T LYMPHOCYTE;

HEPATITIS C VIRUS;

ADULT; ANTIGENS, CD; ANTIGENS, CD274; ANTIGENS, CD86; DENDRITIC CELLS; DOWN-REGULATION; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; LYMPHOCYTE ACTIVATION; MALE; T-LYMPHOCYTES;

EID: 77954409827     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21809     Document Type: Article

References (45)

1. Abe M, Wang Z, de Creus A, Thomson AW. 2005. Plasmacytoid dendritic cell precursors induce allogeneic T-cell hyporesponsiveness and prolong heart graft survival. Am J Transplant 5:1808-1819. (Pubitemid 41039853)
2. Anthony DD, Yonkers NL, Post AB, Asaad R, Heinzel FP, Lederman MM, Lehmann PV, Valdez H. 2004. Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection. J Immunol 172:4907-4916. (Pubitemid 38456415)
3. Bain C, Fatmi A, Zoulim F, Zarski JP, Trepo C, Inchauspe G. 2001. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 120:512-524. (Pubitemid 32147649)
4. Boni C, Fisicaro P, Valdatta C, Amadei B, Di Vincenzo P, Giuberti T, Laccabue D, Zerbini A, Cavalli A, Missale G, Bertoletti A, Ferrari C. 2007. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol 81:4215-4225. (Pubitemid 46586915)
5. Bowen DG, Walker CM. 2005. Adaptive immuneresponses in acute and chronic hepatitis C virus infection. Nature 436:946-952. (Pubitemid 41191670)
6. Chen L, Zhang Z, Chen W, Zhang Z, Li Y, Shi M, Zhang J, Chen L,Wang S, Wang FS. 2007. B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B. J Immunol 178:6634-6641.
7. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S, Mackey EW, Miller JD, Leslie AJ, DePierres C, Mncube Z, Duraiswamy J, Zhu B, Eichbaum Q, Altfeld M, Wherry EJ, Coovadia HM, Goulder PJ, Klenerman P, Ahmed R, Freeman GJ, Walker BD. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443:350-354.
8. Dolganiuc A, Kodys K, Kopasz A, Marshall C, Do T, Romics L, Jr., Mandrekar P, Zapp M, Szabo G. 2003. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J Immunol 170: 5615-5624.
9. Dong H, Zhu G, Tamada K, Chen L. 1999. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 5:1365-1369.
10. Ferrari C. 2007. T and B cells in hepatitis C virus control: What they do and when they fail. Gastroenterology 132:801-805.
11. Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, Fitz LJ, Malenkovich N, Okazaki T, Byrne MC, Horton HF, Fouser L, Carter L, Ling V, Bowman MR, Carreno BM, Collins M, Wood CR, Honjo T. 2000. Engagement of the PD-1 immuno-inhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 192: 1027-1034.
12. Goutagny N, Fatmi A, DeLedinghen V, Penin F, Couzigou P, Inchauspe G, Bain C. 2003. Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection. J Infect Dis 187:1951-1958.
13. Kakimi K. 2003. Immune-based novel therapies for chronic hepatitis C virus infection. Hum Cell 16:191-197.
14. Kanto T, Hayashi N, Takehara T, Tatsumi T, Kuzushita N, Ito A, Sasaki Y, Kasahara A, Hori M. 1999. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol 162:5584-5591.
15. Kanto T, Inoue M, Miyatake H, Sato A, Sakakibara M, Yakushijin T, Oki C, Itose I, Hiramatsu N, Takehara T, Kasahara A, Hayashi N. 2004. Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J Infect Dis 190:1919-1926.
16. Kanto T, Inoue M, Miyazaki M, Itose I, Miyatake H, Sakakibara M, Yakushijin T, Kaimori A, Oki C, Hiramatsu N, Kasahara A, Hayashi N. 2006. Impaired function of dendritic cells circulating in patients infected with hepatitis C virus who have persistently normal alanine aminotransferase levels. Intervirology 49:58-63.
17. Kuipers H, Muskens F, Willart M, Hijdra D, van Assema FB, Coyle AJ, Hoogsteden HC, Lambrecht BN. 2006. Contribution of the PD-1ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation. Eur J Immunol 36:2472-2482. (Pubitemid 44420603)
18. Larsson M. 2006. The dendritic cell: The immune system's adjuvant - a strategy to develop a HCV vaccine? Gastroenterology 130:603-606.
19. Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, Dohrenwend P, Robbins G, Phillips R, Klenerman P, Walker BD. 2000. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191:1499-1512.
20. Liang H, Russell RS, Yonkers NL, McDonald D, Rodriguez B, Harding CV, Anthony DD. 2009. Differential effects of hepatitis C virus JFH1 on human myeloid and plasmacytoid dendritic cells. J Virol 83:5693-5707.
21. Lin L, Fevery J, Hiem Yap S. 2002. A novel strand-specific RT-PCR for detection of hepatitis C virus negative-strand RNA (replicative intermediate): Evidence of absence or very low level of HCV replication in peripheral blood mononuclear cells. J Virol Meth 100:97-105. (Pubitemid 34003628)
22. Liu YJ. 2001.Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106:259-262.
23. Longman RS, Talal AH, Jacobson IM, Rice CM, Albert ML. 2005. Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C. J Infect Dis 192:497-503. (Pubitemid 41023130)
24. Martin-Orozco N, Wang YH, Yagita H, Dong C. 2006. Cutting Edge: Programmed death (PD) ligand-1/PD-1 interaction is required for CD8+ T cell tolerance to tissue antigens. J Immunol 177:8291-8295. (Pubitemid 44893788)
25. Murakami H, Akbar SM, Matsui H, Horiike N, Onji M. 2004. Decreased interferon-alpha production and impaired T helper 1 polarization by dendritic cells from patients with chronic hepatitis C. Clin Exp Immunol 137:559-565. (Pubitemid 39128083)
26. Navas MC, Fuchs A, Schvoerer E, Bohbot A, Aubertin AM, Stoll-Keller F. 2002. Dendritic cell susceptibility to hepatitis C virus genotype 1 infection. J Med Virol 67:152-161. (Pubitemid 34493429)
27. Okazaki T, Honjo T. 2006. The PD-1-PD-L pathway in immunological tolerance. Trends Immunol 27:195-201.
28. Pachiadakis I, Pollara G, Chain BM, Naoumov NV. 2005. Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence? Lancet Infect Dis 5:296-304.
29. Penna A, Pilli M, Zerbini A, Orlandini A, Mezzadri S, Sacchelli L, Missale G, Ferrari C. 2007. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection. Hepatology (Baltimore, MD) 45:588-601.
30. Petrovas C, Casazza JP, Brenchley JM, Price DA, Gostick E, Adams WC, Precopio ML, Schacker T, Roederer M, Douek DC, Koup RA. 2006. PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J Exp Med 203:2281-2292.
31. Piccioli D, Tavarini S, Nuti S, Colombatto P, Brunetto M, Bonino F, Ciccorossi P, Zorat F, Pozzato G, Comar C, Abrignani S, Wack A. 2005. Comparable functions of plasmacytoid andmonocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors. J Hepatol 42:61-67.
32. Sarobe P, Lasarte JJ, Zabaleta A, Arribillaga L, Arina A, Melero I, Borras-Cuesta F, Prieto J. 2003. Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses. J Virol 77:10862-10871.
33. Shepard CW, Finelli L, Alter MJ. 2005. Global epidemiology ofhepatitis C virus infection. Lancet Infect Dis 5:558-567.
34. Steinman RM. 1991. The dendritic cell system and its role in immunogenicity. Ann Rev Immunol 9:271-296.
35. Steinman RM. 2003. Some interfaces of dendritic cell biology. Apmis 111:675-697.
36. Szabo G, Dolganiuc A. 2005. Subversion of plasmacytoid and myeloid dendritic cell functions in chronic HCV infection. Immunobiology 210:237-247.
37. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. 2001. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 194:1395-1406.
38. Trautmann L, Said EA, Halwani R, Janbazian L, Chomont N, El-Far M, Breton G, Haddad EK, Sekaly RP. 2007. Programmed death 1: A critical regulator of T-cell function and a strong target for immunotherapies for chronic viral infections. Curr Opin HIV AIDS 2:219-227.
39. Tsubouchi E, Akbar SM, Horiike N, Onji M. 2004. Infection and dysfunction of circulating blood dendritic cells and their subsets in chronic hepatitis C virus infection. J Gastroenterol 39:754-762. (Pubitemid 39264144)
40. Ulsenheimer A, Gerlach JT, Jung MC, Gruener N, Wachtler M, Backmund M, Santantonio T, Schraut W, Heeg MH, Schirren CA, Zachoval R, Pape GR, Diepolder HM. 2005. Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection. Hepatology (Baltimore, MD) 41:643-651.
41. Urbani S, Amadei B, Tola D, Massari M, Schivazappa S, Missale G, Ferrari C. 2006. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J Virol 80:11398-11403. (Pubitemid 44706581)
42. Urbani S, Amadei B, Tola D, Pedrazzi G, Sacchelli L, Cavallo MC, Orlandini A, Missale G, Ferrari C. 2008. Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: Effect of viremia levels and antiviral treatment. J Hepatol 48:548-558.
43. Yonkers NL, Rodriguez B, Milkovich KA, Asaad R, Lederman MM, Heeger PS, Anthony DD. 2007. TLR ligand-dependent activation of naive CD4 T cells by plasmacytoid dendritic cells is impaired in hepatitis C virus infection. J Immunol 178:4436-4444. (Pubitemid 46492395)
44. Zhang JY, Zhang Z, Wang X, Fu JL, Yao J, Jiao Y, Chen L, Zhang H, Wei J, Jin L, Shi M, Gao GF, Wu H, Wang FS. 2007. PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors. Blood 109:4671-4678.
45. Zhang Z, Jin B, Zhang JY, Xu B, Wang H, Shi M, Wherry EJ, Lau GK, Wang FS. 2009. Dynamic decrease in PD-1 expression correlates with HBV-specific memory CD8 T-cell development in acute selflimited hepatitis B patients. J Hepatol 50:1163-1173.